1. Home
  2. HYFT vs BTMD Comparison

HYFT vs BTMD Comparison

Compare HYFT & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HYFT

MindWalk Holdings Corp.

SELL

Current Price

$1.76

Market Cap

71.9M

Sector

Health Care

ML Signal

SELL

Logo Biote Corp.

BTMD

Biote Corp.

HOLD

Current Price

$2.00

Market Cap

72.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HYFT
BTMD
Founded
1983
2012
Country
United States
United States
Employees
102
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
71.9M
72.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
HYFT
BTMD
Price
$1.76
$2.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$5.00
$2.83
AVG Volume (30 Days)
448.7K
216.3K
Earning Date
03-12-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
722.22
EPS
N/A
0.06
Revenue
N/A
$192,219,000.00
Revenue This Year
N/A
$2.03
Revenue Next Year
$29.18
$6.58
P/E Ratio
N/A
$33.58
Revenue Growth
N/A
N/A
52 Week Low
$0.99
$1.27
52 Week High
$3.00
$4.75

Technical Indicators

Market Signals
Indicator
HYFT
BTMD
Relative Strength Index (RSI) 69.74 48.40
Support Level $1.56 $1.97
Resistance Level $1.93 $2.17
Average True Range (ATR) 0.16 0.14
MACD 0.05 -0.02
Stochastic Oscillator 72.15 37.58

Price Performance

Historical Comparison
HYFT
BTMD

About HYFT MindWalk Holdings Corp.

MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.

About BTMD Biote Corp.

Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.

Share on Social Networks: